Canaccord Genuity Group Initiates Coverage on Niagen Bioscience (NASDAQ:NAGE)
Canaccord Genuity Group assumed coverage on shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) in a research report sent to investors on Tuesday, Marketbeat reports. The brokerage issued a buy rating and a $13.00 price target on the stock. Niagen Bioscience Price Performance Shares of NAGE opened at $10.60 on Tuesday. The business has a […]
Canaccord Genuity Group assumed coverage on shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) in a research report sent to investors on Tuesday, Marketbeat reports. The brokerage issued a buy rating and a $13.00 price target on the stock. Niagen Bioscience Price Performance Shares of NAGE opened at $10.60 on Tuesday. The business has a […]
